Gold prices settled Thursday at their highest level in four weeks, defying their usual inverse relationship with strength in ...

Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

The best tech tutorials and in-depth reviews Try a single issue or save on a subscription Issues delivered straight to your ...

ARKF ETF has sold $15 million worth of shares of Palantir stock, may have caused a bit of a sell-off. See why I maintain a ...

Taking the best bits from our award finalists this year, this latest creation is electric with power, style, and three rows ...

The early weeks of January are a wonderful time to reshuffle your stock portfolio and buy great stocks with big long-term ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Tencent's strong fundamentals and buyback strategy present a buying opportunity despite U.S. blacklisting. Click here to read ...

Indian engineering and technology services firm Tata Elxsi reported a smaller-than-expected third-quarter revenue on Thursday, hurt by sluggish demand in its media and communications division.

As part of the sale, New Balance is taking up to 30% off sitewide with deals from $8. The sale includes sneakers, apparel, ...

Is this the wake-up call to transfer your investments to reputable projects? Market veteran Peter Brandt has warned investors ...

Eli Lilly should become a much bigger money machine with multiple growth drivers in its product lineup and a promising ...